Method of treatment with a combination of a PDE4 inhibitor and a leukotriene antagonist
First Claim
Patent Images
1. (Amended) A composition comprising a synergistic combination of i) N-(3,5-dichloropyrid-4-yl)-cyclopropylmethoxy-4-difluoromethoxybenzamide, the pyridyl N-oxide thereof, or a pharmaceutically acceptable salt of either compound;
- and ii) a leukotriene antagonist.
4 Assignments
0 Petitions
Accused Products
Abstract
Bronchial and respiratory disorders are treated by the separate, sequential, or simultaneous administration of i) an amount of N-(3,5-dichloropyrid-4-yl)-cyclopropylmethoxy-4-difluoromethoxybenzamide, the pyridyl N-oxide thereof, or a pharmaceutically acceptable salt of either compound; and ii) an amount of a leukotriene antagonist, wherein the sum of the first and second amounts is a therapeutically effective amount.
-
Citations
6 Claims
-
1. (Amended) A composition comprising a synergistic combination of i) N-(3,5-dichloropyrid-4-yl)-cyclopropylmethoxy-4-difluoromethoxybenzamide, the pyridyl N-oxide thereof, or a pharmaceutically acceptable salt of either compound;
- and ii) a leukotriene antagonist.
- View Dependent Claims (2, 3, 4, 5)
-
6. (Amended) A method of treatment of bronchial and respiratory disorders comprising the separate, sequential, or simultaneous administration of i) a first amount of N-(3,5-dichloropyrid-4-yl)-cyclopropylmethoxy-4-difluoromethoxybenzamide, the pyridyl N-oxide thereof, or a pharmaceutically acceptable salt of either compound;
- and ii) a second amount of a leukotriene antagonist, wherein the sum of the first and second amounts is a therapeutically synergistic effective amount.
Specification